低氧激活的脂质体使口腔癌的协同光动力疗法成为可能
Jiaxuan Chen1,2,3, Xiaodi Xu1,2,3, Kexuan Wang4
1Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China.
Advanced healthcare materials
|February 14, 2025
概括
这项研究引入了一种结合光动力学疗法 (PDT) 和口腔癌低氧激活化疗的新型脂质体系统. 这种双重作用的方法克服了PDT期间的氧气耗尽,提高了治疗效率和免疫反应.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 口腔癌是一个重大的全球健康挑战,死亡率高.
- 光动力疗法 (PDT) 是一种可行的治疗方法,但由于瘤缺氧而受到限制.
- 缺氧,或低氧,通过减少反应性氧物种的产生来阻碍PDT的效率.
研究的目的:
- 开发一种补充性瘤杀伤系统,以增强口腔癌治疗.
- 为了克服PDT诱导的氧气耗尽,使用联合治疗策略.
- 通过整合低氧激活化疗来提高光动力学治疗的疗效.
主要方法:
- 红细胞 (RBC) 衍生的脂质体被工程设计,用甲酸 (FA) 功能化,用于瘤向.
- 脂质体封装了一种光敏感剂 (TPP) 和一种低氧活性化疗药物 (TPZ).
- 激光照射触发了药物释放,增加了缺氧并激活了化疗.
主要成果:
- 联合光动力学疗法和低氧激活化学疗法诱导了显著的细胞亡.
- 治疗策略导致免疫细胞死亡和激活免疫细胞.
- 脂质体药物递送系统表现出良好的生物安全性.
结论:
- 这种新的脂质体系统有效地结合了PDT和口腔癌的缺氧激活化疗.
- 该方法解决瘤缺氧问题,提高治疗结果和免疫反应.
- 这一策略对未来在口腔癌治疗中的临床应用具有前景.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K